Systemic Lupus Erythematous Flashcards
Systemic Lupus Erythematous
inflammatory autoimmune disorder characterized by autoantibodies to nuclear antigens, affect multiple organs, can be drug induced, mainly women
SLE symptoms
rash in ares exposed to sun, joint 90% pts, anemia, leukopenia, thrombocytopenia, glomerulonephritis, CNS, fever, anorexia, malaise, wt loss, pericardium effected
Drug induced lupus four features
sex ratio equal, nephritis and CNS not present, hypocomplementemia and ab to dsDNA are absent, clin features are most lab abnormalities usually revert toward normal when offending drug removed
SLE lab findings
ANA (sensitive but not specific), anti-dsDNA (specific but not sensitive), low serum complement
Treatment of SLE
education and support, antimalarials (hydroxychloroquine), DHEA
Prognosis of SLE
accelerated atherosclerosis, chronic inflam, MI higher
Prevention in SLE
flu vaccine, pneumococcal vaccine, cancer screenings, stop smoking, control CVD
Reynaud Phenomenon
paroxysmal bilateral digital pallor and cyanosis, precipitated by cold or stress, affects young women, usually benign
Pathophysiology of RP
initial phase: mediated by excessive vasoconstriction, well-demarcated digital pallor or cyanosis; recovery phase: vasodilation, leads to intense hyperemia
Secondary RP
less common, associated with rheumatic diseases, severe cases can lead to digital ulceration and gangrene
Reynaud non-pharm treatment
wear gloves or mittens when outside, keep body warm, stop smoking, avoid sympathomimetic drugs
Reynaud pharm treatment
CCBs first line
Scleroderma
a rare chronic disorder characterized by diffuse fibrosis of skin and internal organs, symptoms 30-50 yo, women 2x more affected, limited and diffuse forms
Clinical presentation of scleroderma
initial: hand arthralgia, inflammatory art of hand, reynaud’s phen, skin-thickening, positive ANA
CREST syndrome
found with limited scleroderma, calcinosis of digits, Raynaud, esophageal motility disorder, sclerodactyly, telangiectasia